Examine Opportunities for Growth, Customer Retention & Increased Efficiency in the Obstetrics/Gynecology Hormone & Contraceptive Market.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c88999) has announced the addition of The Obstetrics/Gynecology Hormone & Contraceptive Market: Opportunities for Growth, Customer Retention & Increased Efficiency to their offering.

Sample: N=100 Ob/Gyns currently practicing in the United States

Countries Covered: United States

Applicability: The information presented in this report has direct applicability to sales, marketing, professional education, advertising, public relations, forecasting, market research and other business functions.

Why purchase this report?

Determine the potential for pharmaceutical treatments in the Obstetrics and Gynecology market, including AUB hormone therapy and birth control therapy / contraceptives, by gaining knowledge of treatment share (i.e. the percentage of birth control patients electing a birth control medical device, the percent electing an oral contraceptive, the percent electing non-oral birth control, etc.)

Acquire new customers by improving sales rep and professional education messages to Obstetricians and Gynecologists

Retain customers by learning how sales reps can connect with Ob/Gyns to increase customer satisfaction and loyalty

Mitigate competitive threats by determining how your company's reps compare to your competitors

Improve your professional education events by determining how your company's events compare to your competitors

Increase attendance of your professional education events by incorporating Ob/Gyns doctors' feedback on incentives and quality of your events, relative to the 17 featured pharmaceutical companies.

Capitalize on unoccupied positions and unmet needs with our Opportunity Index, which illustrates the relative competitive positioning of 17 leading pharmaceutical companies based on their performance in 10 critical business areas (prioritized by importance).

Communicate on your company's strengths to Ob/Gyn doctors and improve in areas of relative weakness.

Understand Ob/Gyn doctors' awareness, experience and use of 79 featured pharmaceutical brands from 4 therapeutic categories (AUB hormone therapy, oral birth control / oral contraceptives, non-oral birth control / contraceptives and birth control devices.)

Evaluate market share as well as Ob/Gyn practitioners' levels of satisfaction and loyalty for each of the 79 featured pharmaceutical brands.

Read voice-of-the-customers feedback directly from Ob/Gyns (in their own words) that provide you with simple, actionable steps to: acquire new customers, prevent current customers from discontinuing use of your products, increase customers' loyalty to your products and increase satisfaction with your products.

Exploit your competitors' weaknesses by learning why some Ob/Gyns are dissatisfied with competitors' products, and turn these prospects into loyal, satisfied customers by meeting their unmet needs.

For more information visit http://www.researchandmarkets.com/reports/c88999